News for Pacira BioSciences, Inc. (PCRX)

PR NewswireNEW YORK, March 10, 2025 NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Pacira BioSc

PR NewswireNEW ORLEANS, March 7, 2025 NEW ORLEANS, March 7, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors tha

**media[559055]**

Pacira BioSciences and Golden Entertainment in the Box have been highlighted as Zacks Bull and Bear of the Day

Earnings moving in the right direction and a bounce off technical support sets this stop up nicely.

PR NewswireNEW YORK, March 4, 2025 NEW YORK, March 4, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securit

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioScience

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Pacir

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. ( PCRX). Shareholders

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Pacira BioScie

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. ( PCRX). Shareholder

Pacira BioSciences Inc (PCRX), a leader in non-opioid pain management solutions, announced on February 26, 2025, its participation in two upcoming healthcare co

PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. ( PCRX), the industry leader in its commitment to deliver innovative, non-opioid

Pacira BioSciences Inc (PCRX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $184.36 million, and the ear

PR NewswireLOS ANGELES, Feb. 25, 2025 LOS ANGELES, Feb. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, remind

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences,

PR NewswireNEW YORK, Feb. 24, 2025 NEW YORK, Feb. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Pacira BioScie

PR NewswireNEW YORK, Feb. 22, 2025 NEW YORK, Feb. 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securit

PR NewswireNEW ORLEANS, Feb. 21, 2025 NEW ORLEANS, Feb. 21, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors tha